FXR, PPARA and LXRA activators to treat acne/acneiform condition

Details FXR, PPARA and LXRA activators to treat acne/acneiform condition FXR, PPARA and LXRA activators to treat acne/acneiform condition

1999-02-25

2000-06-06

Jarvis, William R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31335

Patent

active

060719559

ABSTRACT:
Acne vulgaris and acneiform skin conditions are treated by the application of compounds that is juvenile hormone III, 7-methyl-9-(3,3-dimethyloxiranyl)-3-methyl-2,6-nonadienoic acid methyl ester.

REFERENCES:
patent: 4871752 (1989-10-01), L. IIg et al.
patent: 5161481 (1992-11-01), Laufer
patent: 5556844 (1996-09-01), Reichert et al.
patent: 5587367 (1996-12-01), Reichert et al.
patent: 5604262 (1997-02-01), Wood
patent: 5837224 (1998-11-01), Voorhees et al.
Weinberger C., A Model For Farnesoid . . . , Trends In Endo,. And Metab, vol. 7/1, pp. 1-6 (Jan. /1996).
Noonan et al., A hypothetical mechanism . . . , Adv. Exp. Med. Biol., vol. 422, pp. 127-135 (1997).
Hanley et al., Activators of the nuclear . . . , J. Clin. Invest., vol. 100/3, pp. 705-712 (1997).
Kubo et al., Naturally occurring antiacne agents, J. Of Natural Products, vol. 57/1, pp. 9-17, (1994).
M. Duffill et al. (1976) British Journal of Dermatology 94: 355-362.
J.T. Elder et al. (Feb. 1994) Arch Dermatol 130: 216-224.
L. Skov et al. (Feb. 1997) American Journal of Pathology 150(2): 675-683.
G.D. Weinstein et al. (1965) the Journal of Investigative Dermatology 50(3): 254-259.

Affiliated with

Also associated with

Rating

FXR, PPARA and LXRA activators to treat acne/acneiform condition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with FXR, PPARA and LXRA activators to treat acne/acneiform condition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FXR, PPARA and LXRA activators to treat acne/acneiform condition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2214067